Related Experiment Video
Updated: Jul 3, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
Contrasting genetic effects within STAT4 define susceptibility and protection in Leishmania guyanensis Cutaneous
Lener Santos da Silva1,2, Josué Lacerda de Souza1,2, Lizandra Stephanny Fernandes Menescal3
1Programa de Pós-Graduação em Biodiversidade e Biotecnologia da Amazonia Legal (Rede Bionorte), Universidade do Estado do Amazonas, Manaus, Brazil.
Background:
Leishmania guyanensis-associated cutaneous leishmaniasis (Lg-CL) is endemic in the Brazilian Amazonas. Despite similar exposure to the pathogen in endemic areas, only a subset of individuals develops disease, suggesting host-genetic control. STAT4 triggers IL-12-dependent Th1 differentiation and IFN-γ production, essential for macrophage-mediated parasite clearance.
Methods:
We performed a case-control study of 802 Lg-CL patients and 842 endemic controls (ECs). Eleven STAT4 variants (10 SNVs and one insertion/deletion) were genotyped. Associations were assessed using logistic regression adjusted for age and sex across multiple genetic models, with haplotype analysis adjusted for age and sex via omnibus and likelihood ratio tests.
Results:
Two SNVs exerted contrasting associations: the rs1031509 T allele increased susceptibility (ORadj=1.5 [95% CI 1.3-1.7], Padj-B= 1.3x10-5), while the rs6434435 A allele conferred protection (ORadj=0.56 [95%CI 0.43- 0.68], Padj-B=2.6x10-8). Omnibus haplotype analysis revealed significant global differences in haplotype distribution between Lg-CL and ECs (Omnibus unadjusted χ² = 55.65, df = 13, P = 3.11×10⁻7, likelihood ratio test χ² = 67.81, df = 13, P = 2.02×10⁻9), with a specific high-risk combination (AIGAAAGCTGC) associated with a nine-fold increase in susceptibility (adjusted OR = 9.12 [95%CI 4.22-19.70], P=1.9×10⁻8; FDR q=2.4×10⁻7). Genotype-cytokines analyses revealed that carriers of the protected rs6434435 A allele had significantly higher TNF-α plasma levels under dominant model (+40.2%, FDR adjusted P = 0.026) and additive model, with a nominal trend toward elevated IFN-γ.
Conclusions:
Haplotypic variation at this locus significantly shapes host inflammatory responses, highlighting STAT4 as a key immunogenetic determinant of resistance to Leishmania infection.
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Leishmaniasis
Malaria
Antiprotozoal Agents

